Nexalin Technology NXL
NASDAQ NXL
$4.87 -0.18 (-3.56%)
At close: Sep 10, 2026 · 4:00 PM EDT

Nexalin Technology (NXL) EPS (Diluted) (2022 - 2026)

Analysis

Nexalin Technology (NXL) EPS (Diluted) (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 0.53
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 2.30
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 1.15
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 3.31
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 0.61
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 0.42
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 0.64
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 2.05
10 Nexalin Technology 3.44 Mn 2.44 Mn 8,897.00 -3.18
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.18
Mar 31, 2026 -3.17
Dec 31, 2025 -4.35
Sep 30, 2025 -3.84
Jun 30, 2025 -3.02
Mar 31, 2025 -4.48
Dec 31, 2024 -9.22
Sep 30, 2024 -6.77
Jun 30, 2024 -5.14
Mar 31, 2024 -4.22
Dec 31, 2023 -3.18
Sep 30, 2023 -9.29
Jun 30, 2023 -3.39
Mar 31, 2023 -3.08
Dec 31, 2022 -3.97
Sep 30, 2022 -1.76
Jun 30, 2022 -2.73